TGen recognized as ‘2014 Economic Driver’ by Greater Phoenix Chamber of CommerceContinue reading
Tag Archives: TGen
Plans unveiled to expand the Phoenix Biomedical Campus
University of Arizona, Phoenix announce plans for new 245,000 square foot Bioscience Project for the Phoenix Biomedical Campus.
New Biosciences Partnership Building on Docket Pending Regents Approval
TGen and Scottsdale Healthcare cancer expert Dr. Von Hoff receives Hope Funds award
Dr. Daniel D. Von Hoff, who has been instrumental in developing numerous new cancer treatments, is among this year’s recipients of the Award of Excellence from the Hope Funds for Cancer Research.Continue reading
TGen-led study discovers genetic cause of rare type of ovarian cancer
Scientific breakthrough could lead to new cancer treatments; study inspired by memory of 22-year-old patientContinue reading
TGen study identifies gene fusion as likely cause of rare type of thyroid cancer
Genomic sequencing of 62-year-old patient leads to new treatment optionContinue reading
TGen-led study spotlights dog DNA role in developing new therapies for human cancers
Study shows timeframe for canine sample analysis fits clinical window for human medical advancementsContinue reading
Dr. Daniel D. Von Hoff named one of ASCO’s 50 Oncology Luminaries
TGen and Scottsdale Healthcare cancer expert Dr. Daniel D. Von Hoff is named one of ASCO’s 50 Oncology Luminaries. Dr. Von Hoff’s research led to development of numerous therapeutic agents, and improved patient care.Continue reading
TGen identifies key protein that helps prevent lung cancer tumors from being destroyed
By eliminating Mcl-1, radiation and chemotherapies could be more effective in treating the most common and deadly of all cancersContinue reading
TGen Physician-In-Chief Dr. Daniel Von Hoff inducted today into exclusive Joshua Lederberg Society
Dr. Von Hoff is honored for advancing FDA approved treatment benefiting pancreatic cancer patientsContinue reading